Possible pharmacokinetic interaction involving ritonavir and docetaxel in a patient with Kaposi's sarcoma

AIDS. 2008 Jun 19;22(10):1237-9. doi: 10.1097/QAD.0b013e328300ca98.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / pharmacokinetics*
  • Contraindications
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 CYP3A Inhibitors
  • Docetaxel
  • Drug Interactions
  • Drug Therapy, Combination
  • Eyelid Neoplasms / drug therapy*
  • HIV Infections / drug therapy
  • HIV Protease Inhibitors / pharmacokinetics*
  • Humans
  • Male
  • Neutropenia / chemically induced
  • Ritonavir / pharmacokinetics*
  • Sarcoma, Kaposi / drug therapy*
  • Taxoids / pharmacokinetics*

Substances

  • Antineoplastic Agents
  • Cytochrome P-450 CYP3A Inhibitors
  • HIV Protease Inhibitors
  • Taxoids
  • Docetaxel
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Ritonavir